Daisuke Douchi

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Michiaki Unno · 12 shared papers, 2017–2026 · strength 2.03
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
2. Masamichi Mizuma · 11 shared papers, 2021–2026 · strength 1.98
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
3. Masahiro Iseki · 7 shared papers, 2023–2026 · strength 1.35
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
4. Shuichi Aoki · 7 shared papers, 2023–2026 · strength 1.35
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
5. Kei Nakagawa · 8 shared papers, 2021–2025 · strength 1.29
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
   • Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y↗
   • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
6. Shimpei Maeda · 6 shared papers, 2023–2026 · strength 1.20
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
7. Mitsuhiro Shimura · 5 shared papers, 2023–2026 · strength 1.04
   • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
   • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
   • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
8. Fuyuhiko Motoi · 5 shared papers, 2017–2025 · strength 0.67
   • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
   • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
   • Paper CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases. DOI 10.21873/anticanres.16724↗
9. Kyohei Ariake · 4 shared papers, 2021–2024 · strength 0.63
   • Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y↗
   • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
   • Paper Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology. DOI 10.1038/s41598-024-67757-5↗
10. Koetsu Inoue · 3 shared papers, 2023–2026 · strength 0.60
    • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
    • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
    • Paper CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases. DOI 10.21873/anticanres.16724↗
11. Takanori Morikawa · 4 shared papers, 2021–2023 · strength 0.58
    • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
    • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
    • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
12. Toru Furukawa · 3 shared papers, 2023–2026 · strength 0.56
    • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
    • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
    • Paper Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology. DOI 10.1038/s41598-024-67757-5↗
13. Koetsu Inoue · 4 shared papers, 2017–2025 · strength 0.56
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
    • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
    • Paper Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. DOI 10.1016/j.pan.2022.11.010↗
14. Takashi Kokumai · 3 shared papers, 2023–2025 · strength 0.52
    • Paper Preoperative Chemotherapy With Gemcitabine for Pancreatic Cancer Causes Zinc Deficiency. DOI 10.1097/mpa.0000000000002396↗
    • Paper Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology. DOI 10.1038/s41598-024-67757-5↗
    • Paper CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases. DOI 10.21873/anticanres.16724↗
15. Atsushi Masamune · 2 shared papers, 2026 · strength 0.49
    • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
    • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
16. Shingo Yoshimachi · 2 shared papers, 2025–2026 · strength 0.44
    • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
17. Naohiro Hirano · 2 shared papers, 2023–2026 · strength 0.40
    • Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
    • Paper [A Case of an Elderly Patient Who Underwent Conversion Resection for Pancreatic Cancer with Positive Peritoneal Cytolog… PMID 36807179↗
18. Jingyu Xun · 2 shared papers, 2023–2024 · strength 0.36
    • Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y↗
    • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
19. Aya Noguchi · 2 shared papers, 2024–2025 · strength 0.35
    • Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
    • Paper Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology. DOI 10.1038/s41598-024-67757-5↗
20. Yuichiro Umino · 1 shared paper, 2026 · strength 0.24
    • Paper Histological treatment response to neoadjuvant chemotherapy predicts the survival outcomes of patients with resectable … DOI 10.1007/s00595-026-03325-w↗
21. Kent Miyazaki · 1 shared paper, 2024 · strength 0.20
    • Paper GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthet… DOI 10.1007/s10585-024-10298-y↗
22. Shuhei Kawasaki · 2 shared papers, 2017–2021 · strength 0.17
    • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗
    • Paper MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction… DOI 10.1097/mpa.0000000000000778↗
23. Katsuya Hirose · 1 shared paper, 2023 · strength 0.16
    • Paper Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine ch… DOI 10.1186/s12885-023-11294-3↗
24. Ruri Yamaguchi · 1 shared paper, 2024 · strength 0.16
    • Paper Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology. DOI 10.1038/s41598-024-67757-5↗
25. Masaki Sato · 1 shared paper, 2021 · strength 0.11
    • Paper Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signali… DOI 10.1016/j.pan.2021.02.018↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.